Literature DB >> 17188246

Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice.

Can-Xiang Cao1, Qing-Wu Yang, Feng-Lin Lv, Jie Cui, Hua-Bin Fu, Jing-Zhou Wang.   

Abstract

Inflammatory reaction plays an important role in cerebral ischemia-reperfusion injury, however, its mechanism is still unclear. Our study aims to explore the function of Toll-like receptor 4 (TLR4) in the process of cerebral ischemia-reperfusion. We made middle cerebral artery ischemia-reperfusion model in mice with line embolism method. Compared with C3H/OuJ mice, scores of cerebral water content, cerebral infarct size and neurologic impairment in C3H/Hej mice were obviously lower after 6 h ischemia and 24 h reperfusion. Light microscopic and electron microscopic results showed that cerebral ischemia-reperfusion injury in C3H/Hej mice was less serious than that in C3H/OuJ mice. TNF-alpha and IL-6 contents in C3H/HeJ mice were obviously lower than that in C3H/OuJ mice with ELISA. The results showed that TLR4 participates in the process of cerebral ischemia-reperfusion injury probably through decrease of inflammatory cytokines. TLR4 may become a new target for prevention of cerebral ischemia-reperfusion injury. Our study suggests that TLR4 is one of the mechanisms of cerebral ischemia-reperfusion injury besides its important role in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188246     DOI: 10.1016/j.bbrc.2006.12.057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  117 in total

1.  Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death.

Authors:  Jinpyo Hong; Ik-Hyun Cho; Kyung Il Kwak; Eun Cheng Suh; Jinsoo Seo; Hyun Jung Min; Se-Young Choi; Chong-Hyun Kim; Seung Hwa Park; Eun-Kyeong Jo; Soojin Lee; Kyung Eun Lee; Sung Joong Lee
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

3.  Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism.

Authors:  Philberta Y Leung; Susan L Stevens; Amy E B Packard; Nikola S Lessov; Tao Yang; Valerie K Conrad; Noortje N A M van den Dungen; Roger P Simon; Mary P Stenzel-Poore
Journal:  Stroke       Date:  2012-03-08       Impact factor: 7.914

4.  Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway.

Authors:  Li Zhang; Michael Chopp; Xianshuang Liu; Hua Teng; Tao Tang; Haifa Kassis; Zheng Gang Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

Review 5.  Ischemia-reperfusion and immediate T cell responses.

Authors:  Yanfei Huang; Hamid Rabb; Karl L Womer
Journal:  Cell Immunol       Date:  2007-10-17       Impact factor: 4.868

Review 6.  Mechanisms of ischemic brain damage.

Authors:  Kristian P Doyle; Roger P Simon; Mary P Stenzel-Poore
Journal:  Neuropharmacology       Date:  2008-01-25       Impact factor: 5.250

Review 7.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 8.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

9.  TLR3 ligand Poly IC Attenuates Reactive Astrogliosis and Improves Recovery of Rats after Focal Cerebral Ischemia.

Authors:  Yang Li; Xu-Lin Xu; Dan Zhao; Lin-Na Pan; Chun-Wei Huang; Lian-Jun Guo; Qing Lu; Jian Wang
Journal:  CNS Neurosci Ther       Date:  2015-11       Impact factor: 5.243

Review 10.  A clear and present danger: endogenous ligands of Toll-like receptors.

Authors:  Jacob A Sloane; Daina Blitz; Zachary Margolin; Timothy Vartanian
Journal:  Neuromolecular Med       Date:  2009-10-14       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.